Frederik Persson

15.2k total citations · 3 hit papers
182 papers, 6.3k citations indexed

About

Frederik Persson is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Frederik Persson has authored 182 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Endocrinology, Diabetes and Metabolism, 57 papers in Nephrology and 56 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Frederik Persson's work include Diabetes Treatment and Management (82 papers), Chronic Kidney Disease and Diabetes (47 papers) and Diabetes Management and Research (41 papers). Frederik Persson is often cited by papers focused on Diabetes Treatment and Management (82 papers), Chronic Kidney Disease and Diabetes (47 papers) and Diabetes Management and Research (41 papers). Frederik Persson collaborates with scholars based in Denmark, Netherlands and United Kingdom. Frederik Persson's co-authors include Peter Rossing, Hans‐Henrik Parving, Norman K. Hollenberg, Edmund J. Lewis, Julia B. Lewis, Dick de Zeeuw, Hiddo J.L. Heerspink, Tine W. Hansen, Nish Chaturvedi and John J.V. McMurray and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Diabetes Care.

In The Last Decade

Frederik Persson

175 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

2012 863 citations Hans‐Henrik Parving, John J.V. McMurray et al. profile →
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

2008 744 citations Hans‐Henrik Parving, Frederik Persson et al. profile →
Combination therapy for kidney disease in people with diabetes mellitus

2024 45 citations Daniël H. van Raalte, Frederik Persson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frederik Persson Denmark	40	3.3k	2.4k	1.9k	1.2k	991	182	6.3k
Richard J. MacIsaac Australia	46	2.8k 0.8×	1.1k 0.5×	2.5k 1.3×	783 0.6×	882 0.9×	227	6.9k
Roberto Trevisan Italy	38	2.7k 0.8×	1.3k 0.5×	1.8k 0.9×	771 0.6×	880 0.9×	126	5.3k
Roberto Pontremoli Italy	42	1.4k 0.4×	2.5k 1.1×	2.3k 1.2×	659 0.5×	810 0.8×	214	5.6k
Giuseppe Penno Italy	40	1.8k 0.5×	1.4k 0.6×	1.3k 0.7×	671 0.5×	605 0.6×	150	4.6k
Paola Fioretto Italy	53	4.1k 1.2×	1.9k 0.8×	4.5k 2.4×	1.9k 1.5×	2.0k 2.1×	201	10.2k
Giacomo Deferrari Italy	40	1.1k 0.3×	2.1k 0.9×	2.3k 1.2×	721 0.6×	575 0.6×	160	5.4k
Roberto Zatz Brazil	37	1.2k 0.4×	2.1k 0.9×	2.3k 1.2×	1.2k 1.0×	578 0.6×	119	6.1k
Luís Henrique Santos Canani Brazil	39	1.8k 0.5×	1.1k 0.5×	1.2k 0.6×	1.3k 1.1×	786 0.8×	204	6.3k
Naoki Kashihara Japan	42	1.1k 0.3×	878 0.4×	2.1k 1.1×	1.7k 1.4×	868 0.9×	251	6.2k
Sharon Anderson United States	42	1.6k 0.5×	2.8k 1.2×	3.5k 1.8×	1.7k 1.4×	688 0.7×	117	9.1k

Countries citing papers authored by Frederik Persson

Since Specialization

Citations

This map shows the geographic impact of Frederik Persson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederik Persson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederik Persson more than expected).

Fields of papers citing papers by Frederik Persson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederik Persson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederik Persson. The network helps show where Frederik Persson may publish in the future.

Co-authorship network of co-authors of Frederik Persson

This figure shows the co-authorship network connecting the top 25 collaborators of Frederik Persson. A scholar is included among the top collaborators of Frederik Persson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederik Persson. Frederik Persson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wodschow, Helena Zander, Nicole Jacqueline Jensen, Frederik Persson, et al.. (2025). Protocol for a 1‐year randomised, controlled, parallel group, open‐label trial on the effects and feasibility of time‐restricted eating in individuals with type 2 diabetes‐ The REStricted Eating Time in the treatment of type 2 diabetes (RESET2) trial. Diabetic Medicine. 42(5). e15506–e15506. 2 indexed citations

Persson, Frederik, Jonatan I. Bagger, Dorte Lindqvist Hansen, et al.. (2025). Time-Restricted Eating is a Feasible Dietary Strategy in the Treatment of Complicated Type 2 Diabetes: The RESET2 Pilot Study. Journal of Nutrition Education and Behavior. 57(8). 767–777. 1 indexed citations

Willaing, Ingrid, et al.. (2024). “I Haven’t Told Anyone but You”: Experiences and Biopsychosocial Support Needs of People With Type 2 Diabetes and Binge Eating. Qualitative Health Research. 34(7). 621–634. 3 indexed citations

Persson, Frederik, Mikkel Christensen, Margit Kriegbaum, et al.. (2024). The development of type 2 diabetes management in people with severe mental illness in the Capital Region of Denmark from 2001 to 2015. Acta Psychiatrica Scandinavica. 149(3). 219–233. 1 indexed citations

Persson, Frederik, et al.. (2024). Bone mineral density and the risk of kidney disease in patients with type 1 diabetes. Journal of Diabetes and its Complications. 39(2). 108927–108927. 1 indexed citations

Ahluwalia, Tarunveer S., Mie K. Eickhoff, Viktor Rotbain Curovic, et al.. (2023). Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease. Kidney International Reports. 9(2). 334–346. 5 indexed citations

Borg, Rikke, Nicholas Carlson, Jens Søndergaard, & Frederik Persson. (2023). The Growing Challenge of Chronic Kidney Disease: An Overview of Current Knowledge. International Journal of Nephrology. 2023. 1–8. 38 indexed citations

Persson, Frederik, Niels Jongs, Gozewijn D. Laverman, et al.. (2023). Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study. Diabetes Care. 46(3). 602–607. 9 indexed citations

Curovic, Viktor Rotbain, Morten Baltzer Houlind, Niels Jongs, et al.. (2023). Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes. Diabetes Obesity and Metabolism. 25(11). 3152–3160. 1 indexed citations

10.

Borg, Rikke, Margit Kriegbaum, Christen Lykkegaard Andersen, & Frederik Persson. (2023). #2976 CHRONIC KIDNEY DISEASE WITH COMORBIDITY IN PRIMARY CARE: CARDIORENAL TREATMENT, QUALITY OF CARE AND PROGNOSIS. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations

11.

Møller, Marie, Rikke Borg, Iain Bressendorff, et al.. (2023). Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study). BMJ Open. 13(6). e072216–e072216.

12.

Larsen, Emil List, Daniël H. van Raalte, Marcel H.A. Muskiet, et al.. (2021). The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes. Scientific Reports. 11(1). 10624–10624. 13 indexed citations

13.

Færch, Kristine, Martin Bæk Blond, Hanan Amadid, et al.. (2020). The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial. Diabetologia. 64(1). 42–55. 30 indexed citations

14.

Curovic, Viktor Rotbain, Simone Theilade, Signe Abitz Winther, et al.. (2020). Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes. Diabetic Medicine. 38(5). e14459–e14459. 5 indexed citations

15.

Persson, Frederik, et al.. (2020). Oral treatment of glucocorticoid‐induced diabetes mellitus: A systematic review. International Journal of Clinical Practice. 74(8). e13529–e13529. 4 indexed citations

16.

Eickhoff, Mie K., Claire C. J. Dekkers, Gozewijn D. Laverman, et al.. (2019). Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors. Journal of Clinical Medicine. 8(6). 779–779. 71 indexed citations

17.

Oellgaard, Jens, Peter Gæde, Frederik Persson, et al.. (2018). Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria. Journal of Diabetes and its Complications. 32(12). 1133–1140. 7 indexed citations

18.

Christensen, Robin, Frederik Persson, Brian Bridal Løgstrup, et al.. (2016). Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial. BMJ Open. 6(4). e009134–e009134. 12 indexed citations

19.

Nielsen, Stine E., Frederik Persson, Erik Frandsen, et al.. (2012). Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo‐controlled crossover study. Diabetic Medicine. 29(8). e184–90. 69 indexed citations

20.

Lannek, N., et al.. (1961). A grass disease enzootic in stable-fed horses with an investigation of the aetiological role of the food.. Veterinary Record. 73. 601–603. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact